These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 807548)

  • 21. Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria.
    Kondo S; Iinuma K; Yamamoto H; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1973 Jul; 26(7):412-5. PubMed ID: 4782059
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives.
    Richardson K; Jevons S; Moore JW; Ross BC; Wright JR
    J Antibiot (Tokyo); 1977 Oct; 30(10):843-6. PubMed ID: 591447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mitomycin. 4. Relationship between chemical structures and biological activities of mitomycin derivatives].
    Uzu K; Nakano K; Shimizu M; Kinoshita S; Matsui M
    Jpn J Antibiot; 1971 Aug; 24(4):181-90. PubMed ID: 4999105
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and biological evaluation of novel isoxazolo[4,3-e]indoles as antibacterial agents.
    Pordel M; Abdollahi A; Razavi B
    Bioorg Khim; 2013; 39(2):240-3. PubMed ID: 23964525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues.
    Li J; Wang J; Czyryca PG; Chang H; Orsak TW; Evanson R; Chang CW
    Org Lett; 2004 Apr; 6(9):1381-4. PubMed ID: 15101747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on mitomycins. V. Synthesis of indolequinone and their activities.
    Nakano K; Nishiyama N; Uzu K; Kinoshita S
    J Antibiot (Tokyo); 1971 Jul; 24(7):435-42. PubMed ID: 4998036
    [No Abstract]   [Full Text] [Related]  

  • 27. The synthesis of 1-N-[(S)-4-amino-2-hydroxybutyryl]gentamicin C1 and 1-N-[ (S) -3-amino-2-hydroxypropionyl]gentamicin C1.
    Daniels PJ; Weinstein J; Nagabhushan TL
    J Antibiot (Tokyo); 1974 Nov; 27(11):889-93. PubMed ID: 4217792
    [No Abstract]   [Full Text] [Related]  

  • 28. 3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa.
    Umezawa H; Umezawa S; Tsuchiya T; Okazaki Y
    J Antibiot (Tokyo); 1971 Jul; 24(7):485-7. PubMed ID: 4998037
    [No Abstract]   [Full Text] [Related]  

  • 29. N-(1,1-dihydroperfluorooctyl)pyridinium trifluoromethanesulfonate, a new quaternary ammonium antiseptic.
    Updegraff DM; Kvam DC; Robertson JE
    J Pharm Sci; 1970 Feb; 59(2):188-92. PubMed ID: 4983482
    [No Abstract]   [Full Text] [Related]  

  • 30. Syntheses and properties of the 6"-deoxy or 4",6"-dideoxy derivatives of the kanamycin antibiotics.
    Miyasaka T; Ikeda D; Kondo S; Umezawa H
    J Antibiot (Tokyo); 1980 May; 33(5):527-32. PubMed ID: 7429979
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative clinical pharmacology of amikacin and kanamycin in dairy calves.
    Ziv G
    Am J Vet Res; 1977 Mar; 38(3):337-40. PubMed ID: 403834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial nitrofuran derivatives. I. 5-nitro-2-furaldehyde semicarbazones and thiosemicarbazones.
    Nardi D; Massarani E; Tajana A; Degen L; Magistretti MJ
    J Med Chem; 1967 Jul; 10(4):530-3. PubMed ID: 4962510
    [No Abstract]   [Full Text] [Related]  

  • 33. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
    Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
    J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of 3'.4'-dideoxyneamine active aginst kanamycin-resistant E. coli and P. aeruginosa.
    Umezawa S; Tsuchiya T; Jikihara T; Umezawa H
    J Antibiot (Tokyo); 1971 Oct; 24(10):711-2. PubMed ID: 5003479
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on antiviral agents. IV. Synthesis and in vitro antiviral activity of new N-palmitoylkanamycin A derivatives.
    Matsuda K; Yasuda N; Tsutsumi H; Takaya T
    J Antibiot (Tokyo); 1986 Oct; 39(10):1479-82. PubMed ID: 3023267
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fundamental and clinical studies on BB-K8 (amikacin), a new semisynthetic aminoglycoside antibiotic (author's transl)].
    Ueda Y; Uba F; Go K; Okamoto Y; Okubo H
    Jpn J Antibiot; 1974 Jun; 27(3):354-65. PubMed ID: 4215900
    [No Abstract]   [Full Text] [Related]  

  • 37. Aminoglycoside antibiotics. 5. Regiospecific synthesis of 1-N-[(S)-4-amino-2-hydroxybutyryl]-2"-deoxykanamycin B from neamine.
    Sharma MN; Kumar V; Remers WA
    J Antibiot (Tokyo); 1982 Jul; 35(7):905-10. PubMed ID: 7174540
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of 3',4'-dideoxy and 3',4',5''-trideoxyribostamycin active against kanamycin-resistant E. coli and P. aeruginosa.
    Umezawa S; Tsuchiya T; Ikeda D; Umezawa H
    J Antibiot (Tokyo); 1972 Oct; 25(10):613-6. PubMed ID: 4630694
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Microbiological study of gentamiycin].
    Chaĭkovskaia SM; Vakulenko NA; Braginskaia PS; Makarova RA
    Antibiotiki; 1975 Oct; 20(10):903-7. PubMed ID: 2095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.